Sh2b1 Deficiency Obesity

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-09-08
Clinical Trial Update: An Open-Label Study of Diazoxide Choline in Patients With Genetic Obesities [Phase 2]
An open-label Phase 2 study evaluating diazoxide choline in patients with genetic obesities including SH2B1 deficiency obesity, PCSK1-relate…